{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:22:27Z","timestamp":1788877347576,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177785","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T19:08:01Z","timestamp":1748545681000},"page":"177785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["METTL3-driven m6A modifications in esophageal squamous cell Carcinoma: Emerging mechanisms, biomarker potential, and therapeutic innovations"],"prefix":"10.1016","volume":"1002","author":[{"given":"Hua","family":"Chun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangzhuo","family":"Baima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejphar.2025.177785_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12943-023-01839-2","article-title":"Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma","volume":"22","author":"An","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177785_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejphar.2025.177785_bib3","article-title":"METTL3 promotes esophageal squamous cell carcinoma metastasis through enhancing GLS2 expression","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177785_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12943-019-1033-z","article-title":"The role of m(6)A RNA methylation in human cancer","volume":"18","author":"Chen","year":"2019","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177785_bib5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: from cells to clinic","volume":"38","author":"Diener","year":"2022","journal-title":"Trends Genet."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177785_bib6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/19768354.2024.2417458","article-title":"AP001885.4 promotes the proliferation of esophageal squamous cell carcinoma cells by histone lactylation- and NF-\u03baB (p65)-dependent transcription activation and METTL3-mediated mRNA stability of c-myc","volume":"28","author":"Fu","year":"2024","journal-title":"Anim. Cell Syst."},{"key":"10.1016\/j.ejphar.2025.177785_bib53","doi-asserted-by":"crossref","first-page":"1002565","DOI":"10.3389\/fphar.2022.1002565","article-title":"METTL3\/m(6)A\/IFIT2 regulates proliferation, invasion and immunity in esophageal squamous cell carcinoma","volume":"13","author":"Ge","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177785_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jare.2023.08.014","article-title":"Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma","volume":"61","author":"Guo","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejphar.2025.177785_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.omtn.2021.07.007","article-title":"METTL3-mediated m(6)A mRNA modification promotes esophageal cancer initiation and progression via notch signaling pathway","volume":"26","author":"Han","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"4","key":"10.1016\/j.ejphar.2025.177785_bib9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bbrc.2019.07.058","article-title":"MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m(6)A-caused stabilization of SEC62","volume":"517","author":"He","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177785_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.177785_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101934","article-title":"Exosomal NAT10 from esophageal squamous cell carcinoma cells modulates macrophage lipid metabolism and polarization through ac4C modification of FASN","volume":"45","author":"Jin","year":"2024","journal-title":"Transl. Oncol."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177785_bib12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41418-024-01285-7","article-title":"Unveiling the methionine cycle: a key metabolic signature and NR4A2 as a methionine-responsive oncogene in esophageal squamous cell carcinoma","volume":"31","author":"Jin","year":"2024","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177785_bib14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12033-020-00269-5","article-title":"m6A RNA methylation: ramifications for gene expression and human health","volume":"62","author":"Karthiya","year":"2020","journal-title":"Mol. Biotechnol."},{"issue":"8","key":"10.1016\/j.ejphar.2025.177785_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e29683","article-title":"Lipopolysaccharide promotes cancer cell migration and invasion through METTL3\/PI3K\/AKT signaling in human cholangiocarcinoma","volume":"10","author":"Ke","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177785_bib16","first-page":"613","article-title":"Key genetic determinants driving esophageal squamous cell carcinoma initiation and immune evasion","volume":"165","author":"Ko","year":"2023","journal-title":"Gastroenterology (New York, N. Y., 1943)"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177785_bib17","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.7150\/jca.66830","article-title":"METTL3 facilitates tumor progression by col12a1\/mapk signaling pathway in esophageal squamous cell carcinoma","volume":"13","author":"Li","year":"2022","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177785_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13046-024-03006-x","article-title":"N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1","volume":"43","author":"Li","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.177785_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.116372","article-title":"Effects and mechanisms of N6-methyladenosine RNA methylation in environmental pollutant-induced carcinogenesis","volume":"277","author":"Li","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177785_bib20","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1080\/21655979.2021.1994721","article-title":"Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer","volume":"12","author":"Liang","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.ejphar.2025.177785_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116820","article-title":"STM2457 decreases m6A methylation to reduce cisplatin-induced ototoxicity via MAPK signaling","volume":"235","author":"Liao","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"13","key":"10.1016\/j.ejphar.2025.177785_bib22","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1158\/0008-5472.CAN-21-4124","article-title":"Anti-HIV drug elvitegravir suppresses cancer metastasis via increased proteasomal degradation of m6A methyltransferase METTL3","volume":"82","author":"Liao","year":"2022","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177785_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","article-title":"The m(6)A methyltransferase METTL3 promotes translation in human cancer cells","volume":"62","author":"Lin","year":"2016","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.ejphar.2025.177785_bib24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1158\/1055-9965.EPI-24-1465","article-title":"Absolute risk prediction for esophageal squamous cell carcinoma adaptable to regional disease burden across diverse regions","volume":"34","author":"Liu","year":"2025","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ejphar.2025.177785_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.omto.2021.09.003","article-title":"Exosomal and intracellular miR-320b promotes lymphatic metastasis in esophageal squamous cell carcinoma","volume":"23","author":"Liu","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"issue":"16","key":"10.1016\/j.ejphar.2025.177785_bib26","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.7150\/jca.44754","article-title":"Overexpression of METTL3 associated with the metabolic status on (18)F-FDG PET\/CT in patients with esophageal carcinoma","volume":"11","author":"Liu","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.ejphar.2025.177785_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.591741","article-title":"Angiogenesis in lymph nodes is a critical regulator of immune response and lymphoma growth","volume":"11","author":"Menzel","year":"2020","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.ejphar.2025.177785_bib28","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.molcel.2022.05.029","article-title":"Hidden codes in mRNA: control of gene expression by m(6)A","volume":"82","author":"Murakami","year":"2022","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.ejphar.2025.177785_bib29","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s12029-021-00721-y","article-title":"Systematic review and meta-analysis of the Most common genetic mutations in esophageal squamous cell carcinoma","volume":"53","author":"Naseri","year":"2022","journal-title":"J. Gastrointest. Cancer"},{"issue":"13","key":"10.1016\/j.ejphar.2025.177785_bib30","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1093\/nar\/gkab378","article-title":"A comprehensive review of m6A\/m6Am RNA methyltransferase structures","volume":"49","author":"Oerum","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177785_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.100789","article-title":"How we treat esophageal squamous cell carcinoma","volume":"8","author":"Puhr","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejphar.2025.177785_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148281","article-title":"The METTL3-m(6)A-YTHDC1-AMIGO2 axis contributes to cell proliferation and migration in esophageal squamous cell carcinoma","volume":"908","author":"Qiu","year":"2024","journal-title":"Gene (Amst.)"},{"issue":"4","key":"10.1016\/j.ejphar.2025.177785_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.soc.2013.06.002","article-title":"Targeting angiogenesis and the tumor microenvironment","volume":"22","author":"Samples","year":"2013","journal-title":"Surg. Oncol. Clin."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177785_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70039","article-title":"N(6)-methyladenosine-mediated upregulation of LNCAROD confers radioresistance in esophageal squamous cell carcinoma through stabilizing PARP1","volume":"14","author":"Shi","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"44","key":"10.1016\/j.ejphar.2025.177785_bib35","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1038\/s41388-024-03162-6","article-title":"DDX5 promotes esophageal squamous cell carcinoma growth through sustaining VAV3 mRNA stability","volume":"43","author":"Shi","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2025.177785_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138534","article-title":"m6A-modified circCREBBP enhances radiosensitivity of esophageal squamous cell carcinoma by reducing the stability of MYC through interaction with IGF2BP3","volume":"286","author":"Sun","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177785_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13059-021-02271-9","article-title":"ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism","volume":"22","author":"Tassinari","year":"2021","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177785_bib38","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1038\/s41467-021-23501-5","article-title":"METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N(6)-methyladenosine-dependent YTHDF binding","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177785_bib39","article-title":"Metabolic reprogramming in esophageal squamous cell carcinoma","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.ejphar.2025.177785_bib40","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.7150\/jca.97533","article-title":"N(6)-methyladenosine-modified circ_0006168 promotes epithelial mesenchymal transition via miR-384\/STAT3\/Snail axis in esophageal squamous cell carcinoma","volume":"15","author":"Wu","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.ejphar.2025.177785_bib41","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.2147\/CMAR.S245019","article-title":"Upregulation of METTL3 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma","volume":"12","author":"Xia","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ejphar.2025.177785_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1534655","article-title":"Methyltransferase-like 3 is a target for the diagnose and therapy of clear cell renal carcinoma","volume":"16","author":"Xiao","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177785_bib43","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/j.ymthe.2022.01.046","article-title":"Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment","volume":"30","author":"Xu","year":"2022","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177785_bib44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","article-title":"Roles of METTL3 in cancer: mechanisms and therapeutic targeting","volume":"13","author":"Zeng","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejphar.2025.177785_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101003","article-title":"CircPTEN suppresses human clear cell renal carcinoma progression and resistance to mTOR inhibitors by targeting epigenetic modification","volume":"71","author":"Zhan","year":"2023","journal-title":"Drug Resist. Updates"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177785_bib46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12935-021-01747-9","article-title":"Targeting SNHG3\/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer","volume":"21","author":"Zhang","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177785_bib47","doi-asserted-by":"crossref","first-page":"C329","DOI":"10.1152\/ajpcell.00529.2023","article-title":"METTL3-mediated upregulation of FAM135B promotes EMT of esophageal squamous cell carcinoma via regulating the Wnt\/\u03b2-catenin pathway","volume":"327","author":"Zhang","year":"2024","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177785_bib48","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1038\/s41467-021-25539-x","article-title":"Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.ejphar.2025.177785_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-045655","article-title":"Efficacy of acupuncture in refractory irritable bowel syndrome: study protocol for a randomised controlled trial","volume":"11","author":"Zhao","year":"2021","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177785_bib50","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1038\/s41467-023-39530-1","article-title":"The transcriptional landscape and diagnostic potential of long non-coding RNAs in esophageal squamous cell carcinoma","volume":"14","author":"Zhou","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177785_bib51","article-title":"METTL3 is associated with the malignancy of esophageal squamous cell carcinoma and serves as a potential immunotherapy biomarker","volume":"12","author":"Zhou","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2025.177785_bib52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbrc.2021.05.048","article-title":"The M6A methyltransferase METTL3 regulates proliferation in esophageal squamous cell carcinoma","volume":"580","author":"Zou","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:18:14Z","timestamp":1778876294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925005394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":52,"alternative-id":["S0014299925005394"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177785","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"METTL3-driven m6A modifications in esophageal squamous cell Carcinoma: Emerging mechanisms, biomarker potential, and therapeutic innovations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177785"}}